Harsh S. Shah is working as a senior scientist at J-Star Research Inc. (Cranbury, NJ), where he leads “fit-to-purpose” research projects in drug discovery and drug product development. He is focused on helping to advance by searching physicochemically stable solid forms of new chemical entities, develop and optimizing efficient processes and preformulation studies using advanced analytical and computational techniques. His prior experience includes working at Lachman Institute for Pharmaceutical analysis at Long Island University, collaborative projects with the United States Food & Drug Administration (FDA), Bristol Myers Squibb, Triclinic Labs, Vertex Pharmaceuticals and Amneal Pharmaceuticals. He employs eclectic research approaches to address the challenges encountered throughout drug product development and scale-up. Dr. Shah is a recipient of nationally and internationally recognized awards which include “Research Excellence Award – 2020” by InSc, “PhD Outstanding Student Award – 2020” at Long Island University, and “Academic Research Award – 2019 – 2nd place” at AAPS NERDG annual conference. He has published 17 research papers in Peer-Reviewed Journals and more than 20 abstracts in National & International Conferences. Dr. Shah is an editorial board member for AAPS Open, Asian Journal of Pharmaceutics and International Journal of Science and Pharma Innovations. He is an active member in various professional societies including AAPS, Rho-Chi, IPSE, and ACS. Lab Tour: DS/DP R&D Demo Stations: from material sciences to process development